CdTe-coated magnetic polystyrene nanospheres (MPN) were prepared via a stepwise electrostatic self-assembly approach, and the conjugation of epidermal growth factor (EGF) to the MPN/CdTe core-shell nanocomposites was prepared by using 1-ethyl-3(3-dimethylamino propyl)-carbodiimide (EDC) as a cross-linking reagent. The MPN/CdTe and their bioconjugates yielded not only emitted bright fluorescence, but also exhibited superparamagnetism. The human breast cancer MDA-MB-435S cells could be labelled and rapidly separated by the MPN/CdTe-EGF bioconjugates. These magnetofluorescent nanospheres, consisting of magnetic spheres and quantum dots (QDs), may be of special interest for many biomedical applications.
Introduction
During the past few decades, magnetic nanoparticles (NPs) or spheres (especially Fe 3 O 4 NPs and their composites) have attracted considerable attention owing to their widespread applications in the field of immunoassay, cell separation and molecular biology [1] [2] [3] [4] [5] . Magnetic materials are usually combined with fluorescence [5] [6] [7] [8] [9] [10] [11] [12] for a variety of biomedical applications. For example, Radbruch and coworkers [6] developed homogenously sized large unilamellar liposomes that contain carboxyfluorescein, superparamagnetic particles of 50-100 nm and surface-bound antibodies. These magnetofluorescent composites proved to be useful for the improvement of the sensitivity of detection and physical separation in general and for visualizing and sorting cells according to antigens expressed at low levels. For another example, Kelly and coworkers [10] developed a novel vascular adhesion molecules-1 (VCAM-1)-targeted imaging agents that are detectable by magnetic resonance imaging (MRI) and fluorescence imaging using phage display-derived peptide 3 Author to whom any correspondence should be addressed. sequences and multimodal NPs. These magnetofluorescent NPs-peptide bioconjugates not only successfully identified VCAM-1-expressing endothelial cells in a murine tumour necrosis factor-α (TNF-α)-induced inflammatory model via confocal microscopy, but also allowed in vivo detection of atherosclerotic lesions in apolipoprotein E −/− (apoE −/− ) mice via MRI. Although magnetofluorescent materials have been investigated by many researchers, up to now no reports on magnetofluorescent NPs consisting of quantum dots (QDs) and magnetic polymer spheres have been published to date.
QDs whose radii are smaller than the bulk exciton Bohr radius constitute a class of materials that is intermediate between molecular and bulk forms of matter [13, 14] . Recently, these materials have been the subject of intense research due to interesting optical properties that have many specific applications, primarily as fluorescent labels in biomedical systems [15] . Compared with organic dyes and lanthanide probes, QDs have many important advantages, such as a narrow and symmetric emission spectrum, a broad and continuous excitation spectrum from ultraviolet to infrared wavelengths, high quantum yield, and highly stability against photobleaching [16, 17] . Therefore, magnetic materials combined with QDs may provide important advantages over traditional dyes. For example, to diagnose whether certain tumour cells have metastasized into the blood stream or not, QDs-coated magnetic spheres with different fluorescence colours conjugated with different antibodies can be incubated with several or more millilitres of blood, followed by magnetic separation and fluorescence imaging; according to the fluorescence colour labeled on the surfaces of the cells, the circulating tumour cells and their properties may be detected. The process described above is depicted simply in figure 1. Because different-coloured QDs can be excited simultaneously by a single light source [17] , combining magnetic separation and QD imaging is expected to provide a novel tool for rapid and high-throughput detection.
In this paper, we report on the electrostatic deposition of CdTe QDs onto the magnetically modified polystyrene nanospheres (MPN; Fe 3 O 4 NPs incorporated into the spheres) and the conjugation of epidermal growth factor (EGF) to the MPN/CdTe nanocomposites. We then used these MPN/CdTe-EGF bioconjugates to label and separate the human breast cancer MDA-MB-435S cells.
We know that the EGF family of receptors (EGFR) is overproduced in estrogen receptor (ER) negative (−) breast cancer cells [18] . Also, several lines of evidence have identified the EGFR as a rational target for anticancer therapy [19, 20] . Using the targeting MPN/CdTe-EGF bioconjugates binding to the EGFR overpression MDA-MB-435S cells, it may be demonstrated that the magnetofluorescent nanospheres prepared by this work can be applied simultaneously for cell labelling and separation. Also, different-coloured magnetic-QD nanospheres may be applied in various fields of biomedicine in future work.
Experimental sections
The carboxyl-modified MPN was a gift from Professor Yihua Zhu (East China University of Science and Technology). Amino-PEG powder (purity 98%), MW = 5000, was a gift from Professor Zhirong Wu (East China Normal University). CdCl 2 ·2.5H 2 O, Te powder, NaBH 4 , NaOH, rhodamine 6G and 1-ethyl-3(3-dimethylamino propyl)-carbodiimide (EDC) were purchased from Shanghai Chemical Regent Co. Ltd. Riboflavin (high-purity grade) was purchased from Genebase Gene-Tech Co. Ltd. 3-mercaptopropionic acid (MPA, purity = 99%) was purchased from Aldrich Chemical Company. Poly(diallyldimethylammonium chloride) (PDADMAC, 40 wt%), MW = 7 × 10 5 -1 × 10 6 , was purchased from Shanghai Hengyi Chemical Engineering Corporation. EGF was purchased from Sigma Chemical. The human breast cancer cell line (MDA-MB-435S) and Leibovitz's L-15 medium were ordered from the Chinese Academy of Sciences. Fetal bovine serum (FBS) was purchased from Shanghai Amin Biotechnology Co. Ltd. The water used in all experiments was prepared by a Millipore Milli-Q Plus purification system.
For the typical synthesis of CdTe QDs, fresh NaHTe solution was prepared first by dissolving Te powder into NaBH 4 solution (1:2 molar ratio) under nitrogen atmosphere at room temperature. The NaHTe solution was then added into a solution of CdCl 2 containing MPA. The concentration of CdCl 2 was 1.7 mM, and the molar ratio of Cd to Te to MPA was 1:0.9:9. The pH value of the reaction solution was 9.5 (adjusted by NaOH). The solution was then heated to 95
• C under nitrogen atmosphere flow. About 10 h later, the reaction solution was cooled naturally to room temperature.
For a typical preparation of MPN/CdTe nanocomposites, 50 µl of MPN suspension (about 0.05 nM) were added to 500 µl of PDADMAC aqueous solution (0.5 mg ml −1 , containing 0.5 M NaCl). After sonicating for about 20 min, the mixture solution was precipitated by a small magnet (NdFeB: B H max = 10 mgOe, H c = 600 kA m −1 , M r = B r = 0.7 T), and then washed three times with water to remove the excess PDADMAC. The MPA-capped CdTe solution (1 ml, 1.7 mM, with reference to Cd) was then added to the MPN precipitates under continuous vigorous stirring at room temperature. After 20 min for CdTe QD adsorption, the mixture solution was precipitated by magnetic separation and then washed three times with water. The product was re-dispersed in 50 µl of water. In order to prepare the MPN/CdTe bioconjugates conveniently, the outermost surface layer comprised MPAcapped CdTe QDs, and only a one-layer CdTe shell was prepared in this work.
In order to study whether these MPN/CdTe nanocomposites can be used in biological system or not, bioconjugation of the EGF to MPN/CdTe nanocomposites was prepared and used to label and separate the human breast cancer MDA-MB-435S cells. The experimental details were described as follows. (1) Preparation of the MPN/CdTe-EGF conjugates. The MPN/CdTe suspension was activated with 1 mM of EDC at pH 7.0 and for 30 min at room temperature. After purification by magnetic separation, the activated MPN/CdTe nanocomposites were reacted with amino-PEG at a MPN/PEG molar ratio of 1:5000 at pH 8.0 for 2 h at room temperature, and then with EGF at a MPN/EGF molar ratio of 1:5000 at pH 8.0 overnight at 4
• C (for the convenience of writing, MPN/CdTe nanocomposites conjugated with both PEG and EGF were called just MPN/CdTe-EGF in the following section). Afterwards, the bioconjugate was purified by magnetic separation and dispersed in Leibovitz's L-15 medium (with no FBS). To investigate whether the EGF can be conjugated to the MPA-capped CdTe QDs and whether the CdTe-EGF bioconjugates can recognize the MDA-MB-435S cancer cells, CdTe-EGF bioconjugates were also prepared here and described as follows. MPAcapped CdTe solution was activated with 1 mM EDC at pH 7.0 for 30 min at room temperature. The activated CdTe solution was dialysed in 3500 MWCO dialysis tubing against the CdTe solution (no EDC) at room temperature for about 2 h. After purification, the activated CdTe was reacted with the amino-PEG at a CdTe/PEG molar ratio of 1:5 at pH 8.0 for 2 h at room temperature, and then with EGF at a CdTe/EGF molar ratio of 1:20 at pH 8.0 overnight at 4
• C. The final CdTe conjugates were dialysed in 10 000 MWCO dialysis tubing under Afterwards, the cells were collected by magnetic separation, washed and photographed. As negative controls, MPN/CdTe-EGF was incubated with a cancer cell suspension that had been incubated with free EGF, and MPN/CdTe-PEG (no EGF) was incubated with a cancer cell suspension for 1 h, washed and photographed under the same conditions.
The morphology of the MPN before and after coating with PDADMAC/CdTe was observed by transmission electron microscopy (TEM; a JSM-6360LV from JEOL, Japan). The room-temperature magnetic properties were measured on a vibrating-sample magnetometer (a Physical Property Measurement System from Quantum Design, USA) with a maximum applied field of 1.8 T. Ultraviolet-visible (UVvis) absorption spectra of the MPN, MPN/CdTe, MPN/CdTe-PEG and MPN/CdTe-EGF were taken on a diode array spectrophotometer (a UV-2102PC from Uico, USA) with a deuterium lamp source. Also, the photoluminescence (PL) spectra excited at 400 nm were taken on a fluorescence spectrometer (a F-2500 from Hitachi, Japan) with a xenon lamp source. The quantum yields (QY) of the CdTe QDs in aqueous solution before and after deposition on the surface of the MPNs were determined by comparing the integrated emission to that of Rhodamine 6G in ethanol, using the riboflavin as a calibration reagent, according to the procedure described in [21] . All the optical measurements were taken at room temperature. The bright-field images and the corresponding fluorescent images of the cancer cells were accomplished by using a laser-scanning confocal microscope (a TCS NT from Leica, Germany) with a 63× oil objective. The false-coloured images were obtained with 568 nm excitation and 615 nm detection. Although the magnetism has decreased, the nanocomposites can still be adsorbed quickly and firmly by the small magnet.
Result and discussion
The UV-vis absorption and PL spectra of the samples are shown in figure 4 . It can be seen that the resolved lowest exciton transition (600 nm) in the CdTe absorption spectrum has broadened significantly after the deposition of CdTe QDs on the MPN surfaces. Further conjugations of PEG and EGF result in a flatter absorption curve. At the same time, the emission peak of the CdTe QDs shifts to the red, from 633 to 650 nm, after deposition on the MPN surfaces. This peak does not obviously shift any more after conjugation with PEG and EGF. We know that the optical properties of the QDs are very strongly affected by their surfaces. The variations of the absorption and emission peaks further indicate that CdTe QDs have been deposited on the MPN surfaces, and indicate that MPN/CdTe nanocomposites may have been conjugated with the PEG and EGF molecules. Although the QY of the MPAcapped CdTe QDs decreased from about 19.6% to 2.0% after the CdTe deposition on the MPN surfaces and conjugation with the PEG and EGF molecules, we find that the MPN/CdTe-EGF bioconjugates still emit bright fluorescence.
The binding activities of the CdTe-EGF and MPN/CdTe-EGF bioconjugates to the MDA-MB-435S cells are shown in figures 5 and 6. On optical excitation, CdTe-EGF biocongugates are observed decorating and internalizing the cancer cells, whereas little visible sign of the CdTe-PEG is observed on the cancer cells in the control studies. An interesting finding is that the cancer cells also do not absorb the CdTe QDs without the block of PEG (data not shown). This phenomenon is likely due to a large amount of carboxylic acid groups with excess negative charges on the CdTe QD surfaces. These results establish that: (1) the EGF molecules have been successfully conjugated to the MPA-capped CdTe QDs by using the EDC as a cross-linking reagent; (2) CdTe-EGF biocongugates retain their EGF bioactivity and specificity of cancer cell binding; and (3) the surfaces of the MDA-MB-435S cancer cells may be negatively charged, and nonspecific negatively charged MPA-capped QDs binding to the cells is avoided well. We observe that nearly all the MDA-MB-435S cells are also lit up by the MPN/CdTe-EGF bioconjugates. But the fluorescence of the MPN/CdTe-EGF on the cancer cells is not uniform, and only deposited on the surface of the cells compared with that of the CdTe-EGF. Some cells are covered by a large number of the nanocomposites and only small parts of the cells are observed clearly, whereas some cells are decorated by only a few nanocomposites. This may be caused by the large size of the MPN/CdTe nanocomposites and the very limited Brownian motion of the particles. The distribution of these large particles in the cell solution is therefore not very uniform compared with that of QDs of just several nanometres in diameter. The MPN/CdTe bioconjugates have not been internalized by endocytosis of the cancer cells, which is very important for cell separation. This is the reason why we choose the magnetic spheres but not the small iron oxide NPs [22] for combining with the QDs. Control studies using MPN/CdTe-PEG (without EGF) show a low level of nonspecific binding of the nanocomposites to the cancer cells. Additional control studies using the inhibition of free EGF peptide also show a low level of nonspecific binding. But some MPN/CdTe nanocomposites in the absence of PEG are observed to decorate the cancer cells (data not shown), which is likely due to the excess positively charged PDADMAC molecules in the nanocomposites. So we think that, if the nanocomposites were coated with enough negatively charged polymers, the nonspecific binding might be avoided. Also, this hypothesis is under investigation. These results indicate that MPN/CdTe-EGF can recognize MDA-MB-435S cancel cells, and the block of polymer is very important.
After MDA-MB-435S cell digestion and cell suspension incubation with the MPN/CdTe-EGF bioconjugates and magnetic separation, a large number of the cancer cells are collected, and all these cells are labelled with many fluorescent particles (figure 7). We found that the semitransparent suspension consisting of the bioconjugates and cancer cells became clear within just a few seconds after a magnet came close to the cell suspension. This rapid cell separation process has great advantages in clinical diagnosis. In the control studies, although we also find that some cancer cells are separated by the magnet, a large number of the cells still exist in the Leibovitz's L-15 medium. A few cancer cells can be collected in the control experiments, which may be explanined as follows. (1) of the nanocomposites in the medium, and the cancer cells in these solution layers are therefore taken by the flow of the solution: if the cancer cells are hidden in the precipitates of the nanocomposites, they cannot be removed by washing; this phenomenon may appear in each magnetic separation and washing process, but of course the number of these cells will decrease with increasing washing time. (2) The nonspecific binding of the nanocompostes to the cancer cells may be not blocked completely by the PEG molecules, which will be improved in future work; we know that, although PEG is widely used by many researchers to modify QD NPs, a low level of nonspecific binding still exists, and this is still a challenge in biological studies.
Conclusions
In summary, we have succeeded in fabricating magnetofluorescent nanospheres that simultaneously possess bright fluorescence and magnetism. The EGF-conjugated magnetofluorescent nanospheres can be used to label and rapidly separate the EGFR-overexpressing human breast cancer MDA-MB-435S cells. The assembly steps of the nanocomposites and the bioconjugation process reported in this work are simple and highly efficient. Any other QDs may be coated on the MPN surfaces and other biomolecules (such as proteins, peptides, and DNA, etc) may be conjugated to the MPN/QDs nanocomposites using this approach. Also, this approach offers an interesting tool for use in a range of immunoassay, clinical diagnosis, and various other biomedical applications.
